Predicate Labs
Predicate Labs is pioneering the future of healthcare diagnostics by developing AI-driven early warning systems that leverage wearable biosensors and natural language processing. Their mission is to identify critical illness early, treat quickly, and reduce mortality, with a vision to promote health equity and ensure no early warning sign goes undetected, especially in low-resource settings. Predicate Labs is committed to bringing evidence-based, technology-enabled care to every patient worldwide.
What We Do
An AI-powered diagnostic platform featuring the world's first Bio-Lingual® database, designed to predict the onset of sepsis by actively seeking and analyzing data from wearable biosensors and natural language processing.
A platform that detects warning signs, confirms diagnoses, targets therapy, and reduces trial and error in treatment, with a focus on early identification and rapid intervention for critical illnesses such as sepsis.
Consulting services to help hospitals implement technology-driven strategies, protocolize care, and provide education and training to improve clinical outcomes and reduce costs related to septic shock.
Application Area
Show More (3)Infectious Diseases
Digital Health Technologies
Show More (3)Key People
News & Updates
A 300-bed teaching hospital used Predicate-linked technology to reduce care variation, improve outcomes, and avoid costs related to septic shock, achieving higher compliance with sepsis protocols and significant cost savings.
Announcement of Predicate Labs' collaboration with Mayo Clinic to advance early detection of critical illness using AI-driven technology.